Sarah Ford | November 20, 2014
Drug Restores Memory Function in Alzheimer’s Model
Building on earlier work funded by BrightFocus, researchers have discovered a promising new drug compound that reverses some
Alzheimer’s effects on memory in mice.
Four years ago, a research team led by BrightFocus grantee and Nobel Laureate Dr. Paul Greengard established the connection between increased striatal-enriched tyrosine phosphatase (STEP) levels and Alzheimer’s changes in mice, and showed that removing STEP had the effect of restoring synaptic connections.
Since their discovery of STEP, this research team has been searching for a drug that would block its damaging effects on brain synapses. They focused their efforts on finding a STEP inhibitor, studying thousands of small molecules in their quest.
Get Resources and Insights Straight To Your Inbox
Explore More Articles
Productive Partnerships: Supporting Nonprofits Through CSR Initiatives
Join America’s Charities President and CEO, Jim Starr, along with other panelists on October 30, 2024 at 3:00 PM ET for NXUnite’s panel on Productive…
Read Article
Animal Rescue Team and Disaster Response
The Humane Society of the United States (HSUS) Animal Rescue Team (ART) is on call 24/7, ready to deploy whenever animals are caught in large-scale…
Read Article
Domestic Violence Awareness Month: Together We Can End Domestic Abuse
The U.S. Department of Justice estimates that 1.3 million women and 835,000 men are victims of physical violence by a partner every year. People who are…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.
